Protagonist Therapeutics, Inc. (PTGX)
NASDAQ: PTGX · Real-Time Price · USD
98.97
-3.20 (-3.13%)
At close: Mar 27, 2026, 4:00 PM EDT
99.68
+0.71 (0.71%)
After-hours: Mar 27, 2026, 6:11 PM EDT
Protagonist Therapeutics Market Cap
Protagonist Therapeutics has a market cap or net worth of $6.32 billion as of March 27, 2026. Its market cap has increased by 87.39% in one year.
Market Cap
6.32B
Enterprise Value
5.68B
1-Year Change
87.39%
Ranking
Category
Stock Price
$98.97
Market Cap Chart
Since August 11, 2016, Protagonist Therapeutics's market cap has increased from $171.50M to $6.32B, an increase of 3,582.30%. That is a compound annual growth rate of 45.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 6.32B | 15.66% |
| Dec 31, 2025 | 5.46B | 137.34% |
| Dec 31, 2024 | 2.30B | 73.94% |
| Dec 29, 2023 | 1.32B | 146.39% |
| Dec 30, 2022 | 536.80M | -67.11% |
| Dec 31, 2021 | 1.63B | 111.63% |
| Dec 31, 2020 | 771.30M | 302.14% |
| Dec 31, 2019 | 191.80M | 17.81% |
| Dec 31, 2018 | 162.80M | -61.78% |
| Dec 29, 2017 | 426.00M | 15.89% |
| Dec 30, 2016 | 367.60M | 114.34% |
| Aug 11, 2016 | 171.50M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Halozyme Therapeutics | 7.30B |
| Krystal Biotech | 7.17B |
| Arcellx | 6.72B |
| Kymera Therapeutics | 6.38B |
| Belite Bio | 5.98B |
| Terns Pharmaceuticals | 5.98B |
| Cogent Biosciences | 5.81B |
| Apogee Therapeutics | 5.75B |